Health
Life-extending drug for incurable breast cancer approved for NHS use – The Guardian
About 3,300 women a year may benefit from decision to approve ribociclib
Breast cancerAbout 3,300 women a year may benefit from decision to approve ribociclib
Fri 26 Feb 2021 08.57 EST
Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.
The National Institute for Health and Care Excellence (Nice) has approved the drug ribociclib , also known as Kisqali for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast…
-
Noosa News17 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder
-
Noosa News15 hours agoGirl’s death in a Queensland cult
-
General15 hours agoTeen driver on cocaine racing to Perth nightclub before high-speed crash that killed Nick Campo, court hears
-
Noosa News15 hours agoAirbnb owner hit with disturbing email after house trashed by hundreds of teens